✦ LIBER ✦

Multicenter prospective study of interferon-α versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia: a preliminary analysis

✍ Scribed by Kazunori Ohnishi; Teruo Ino; Yuji Kishimoto; Noriko Usui; Chihiro Shimazaki; Shigeki Ohtake; Hirokuni Taguchi; Shuya Kusumoto; Kazutaka Kuriyama; Tomomitsu Hotta; Ryuzo Ohno

Publisher: Springer
Year: 2001
Tongue: English
Weight: 100 KB
Volume: 48
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800100307

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of imatinib versus in

Cost-effectiveness of imatinib versus interferon-α plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia

✍ Shelby D. Reed; Kevin J. Anstrom; Jennifer A. Ludmer; G. Alastair Glendenning; K 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 1 views

## Abstract ## BACKGROUND Despite a lack of long‐term data, imatinib has become standard therapy for patients with newly diagnosed chronic‐phase chronic myeloid leukemia (CML) who are not candidates for allogeneic stem cell transplantation. In the current study, the authors estimated the increment